Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tegoprubart by Eledon Pharmaceuticals for Kidney Transplant Rejection: Likelihood of Approval
Tegoprubart is under clinical development by Eledon Pharmaceuticals and currently in Phase II for Kidney Transplant Rejection. According to GlobalData,...